Johnny F Railey
USPTO Patent Examiner·Active 2012 to 2017
Johnny F Railey is a USPTO patent examiner who has handled 19 ex parte reexaminations between 2012 and 2017. These reexams concentrate in Chemistry & Materials, Life Sciences & Consumer, and Physics & Instruments. ExamPat indexes the full prosecution record for each of these cases, including office-action grounds, certificate outcomes, and downstream PTAB and federal-circuit decisions.
Filings by year
Technology mix
Compare against all examiners
Eight side-by-side metrics: case volume, pendency, OAs per reexam, rejection mix, SNQ denial rate, certification rate, and PTAB appeal rate, with a Δ column showing where this examiner runs higher or lower than the corpus.
- Average and median pendency, both for this examiner and the corpus
- Rejection basis split (102 / 103 / 112) head-to-head
- Certification, SNQ denial, and PTAB appeal rates
Certificate outcome distribution
How this examiner's certificates split across the six possible outcomes: all claims confirmed, confirmed with amendment, confirmed with new claims, mixed, or all claims canceled. Includes share comparison to the corpus distribution.
- Count and share for each of the six outcome buckets
- Δ vs. corpus distribution in percentage points
- Useful for setting realistic patent-owner expectations
Event-to-event timing
Median time for this examiner's cases at each prosecution stage, from filing to first office action, filing to NIRC, and filing to certificate, with corpus comparison and sample size.
- Median in months per transition
- Side-by-side with the corpus median
- n column showing how many of this examiner's cases completed each transition
vs. all examiners
Certificate outcome distribution
Event-to-event timing (median)
Recent reexaminations (19)
| Control # | Filed | Patent | Title | Pendency | Status |
|---|---|---|---|---|---|
| 90/014,054 | Dec 15, 2017 | 8,883,491 | SYSTEMS AND METHODS FOR COUNTING CELLS AND BIOMOLECULES | 26 mo | Closed |
| 90/014,027 | Oct 10, 2017 | 6,669,967 | METHOD FOR THE TREATMENT OF SYMPTOMS RELATED TO NORMAL HORMONAL VARIATIONS IN WOMEN | 16 mo | Closed |
| 90/013,963 | Jun 14, 2017 | 8,883,157 | Targeting Rare Human PCSK9 Variants for Cholesterol Treatment | 11 mo | Closed |
| 90/013,885 | Dec 27, 2016 | 9,181,527 | T CELL RECEPTOR-DEFICIENT T CELL COMPOSITIONS | — | Closed |
| 90/013,846 | Oct 27, 2016 | 6,174,670 | MONITORING AMPLIFICATION OF DNA DURING PCR | 11 mo | Closed |
| 90/013,709 | Apr 29, 2016 | RE38,551 | ANTICONVULSANT ENANTIOMERIC AMINO ACID DERIVATIVES | 23 mo | Closed |
| 90/013,712 | Mar 29, 2016 | 9,132,156 | Acellular Amnion Derived Therapeutic Compositions | 8 mo | Closed |
| 90/013,657 | Dec 11, 2015 | 7,883,904 | DETECTION AND MONITORING OF LIVER DAMAGE | 10 mo | Closed |
| 90/013,636 | Nov 23, 2015 | 7,910,340 | Process for Producing Coenzyme Q10 | 10 mo | Closed |
| 90/013,541 | Jul 6, 2015 | 8,932,805 | Birth Tissue Material and Method of Preparation | 7 mo | Closed |
| 90/013,524 | Jun 8, 2015 | 7,491,509 | SYSTEM FOR EXPRESSION OF GENES IN PLANTS | 14 mo | Closed |
| 90/013,348 | Sep 19, 2014 | 8,404,750 | Methods for Administration and Formulations for the Treatment of Regional Adipose Tissue | 11 mo | Closed |
| 90/013,336 | Sep 3, 2014 | 8,420,625 | Lipolytic Methods for Regional Adiposity | 11 mo | Closed |
| 90/013,296 | Jul 11, 2014 | 7,348,004 | IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS | 19 mo | Closed |
| 90/013,290 | Jul 8, 2014 | 7,060,431 | Method Of Making And Decoding Of Array Sensors With Microspheres | — | Closed |
| 90/013,242 | Jun 2, 2014 | 7,404,956 | IMMUNOGLOBULIN CHIMERIC MONOMER-DIMER HYBRIDS | 19 mo | Closed |
| 90/012,693 | Sep 20, 2012 | 5,676,968 | Transdermal therapeutic systems with crystallization inhibitors | 32 mo | Closed |
| 90/012,556 | Sep 13, 2012 | 7,459,153 | Viral Vectors for Gene Therapy | 27 mo | Closed |
| 90/012,503 | Sep 12, 2012 | 7,993,889 | FERMENTIVE PRODUCTION OF FOUR CARBON ALCOHOLS | 50 mo | Closed |
| 90/012,310 | May 29, 2012 | 5,858,731 | Oligonucleotide Libraries Useful for Producing Primers | — | Closed |
Get the full reexam analytics
Compare Johnny F Railey against the full corpus, see the certificate-outcome split, drill into event timing, filter the case list, and export. Free to sign up.